- Report
- April 2025
- 175 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- July 2024
- 150 Pages
Global
From €5416EUR$5,950USD£4,600GBP
- Report
- March 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- March 2025
- 250 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- June 2022
- 215 Pages
United States
From €2457EUR$2,699USD£2,086GBP
The Pentacel market is a segment of the vaccine industry that focuses on the development and distribution of combination vaccines. These vaccines are designed to protect against multiple diseases, such as diphtheria, tetanus, pertussis, polio, and Haemophilus influenzae type b (Hib). Pentacel vaccines are typically administered to infants and young children, and are often given in a series of three or four doses.
The Pentacel market is highly competitive, with a number of companies offering combination vaccines. These include Sanofi Pasteur, GlaxoSmithKline, Merck, Pfizer, and Novartis. Each company has its own portfolio of combination vaccines, and they are all striving to develop the most effective and safe products. Show Less Read more